BIOS Capital Management, LP reported 9 holdings worth US$41.7M as of Jun 30, 2026 (Form 13F)
As of Jun 30, 2026 · Filed Aug 14, 2026
BIOS Capital Management, LP reported 9 holdings worth US$41.7M as of Jun 30, 2026. Largest: Actuate Therapeutics, Inc., Opus Genetics, Inc. and Cognition Therapeutics, Inc. Filed Aug 14, 2026 (Form 13F).
- Holdings
- 9
- Value as reported
- US$41.7M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| Actuate Therapeutics, Inc. | 10M | US$15.4M | 36.9% |
| Opus Genetics, Inc. | 3.68M | US$15.1M | 36.3% |
| Cognition Therapeutics, Inc. | 6M | US$6.9M | 16.6% |
| Rein Therapeutics, Inc. | 2.98M | US$3.1M | 7.4% |
| Lantern Pharma Inc. | 249K | US$1.04M | 2.5% |
| In8bio, Inc. | 80,957 | US$114K | 0.27% |